SARS-CoV-2 and probable lung cancer risk

[Image: see text] The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global crisis with a growing number of mortalities and morbidities worldwide. Despite performing numerous researches, there are still considerable unrevealed details regarding the long-term co...

Descripción completa

Detalles Bibliográficos
Autores principales: Khiali, Sajad, Rezagholizadeh, Afra, Entezari-Maleki, Taher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences (TUOMS Publishing Group) 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124879/
https://www.ncbi.nlm.nih.gov/pubmed/35677665
http://dx.doi.org/10.34172/bi.2022.23266
Descripción
Sumario:[Image: see text] The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global crisis with a growing number of mortalities and morbidities worldwide. Despite performing numerous researches, there are still considerable unrevealed details regarding the long-term complications and post-infection immunity of the coronavirus disease 2019 (COVID-19). Based on pathophysiological features, SARS-CoV-2 may act similarly as an oncovirus in the lung. This letter summarized three possible oncogenic mechanisms of SARS-CoV-2 that may be associated with lung cancer development.

Ejemplares similares